SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-19-000071
Filing Date
2019-11-06
Accepted
2019-11-06 12:27:45
Documents
76
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arbutusq32019.htm 10-Q 1050033
2 EXHIBIT 10.1 formofindemnificationagr.htm EX-10.1 21348
3 EXHIBIT 10.3 boardagreementcheng.htm EX-10.3 632
4 EXHIBIT 31.1 exhibit311q32019.htm EX-31.1 13512
5 EXHIBIT 31.2 exhibit312q32019.htm EX-31.2 13976
6 EXHIBIT 32.1 exhibit321q32019.htm EX-32.1 6617
7 EXHIBIT 32.2 exhibit322q32019.htm EX-32.2 6903
14 boardagreementcheng001.jpg GRAPHIC 195022
15 formofindemnificationagr001.jpg GRAPHIC 150421
16 formofindemnificationagr002.jpg GRAPHIC 229677
17 formofindemnificationagr003.jpg GRAPHIC 186389
18 formofindemnificationagr004.jpg GRAPHIC 257283
19 formofindemnificationagr005.jpg GRAPHIC 201957
20 formofindemnificationagr006.jpg GRAPHIC 43291
21 formofindemnificationagr007.jpg GRAPHIC 69221
22 hbvpipeline002.jpg GRAPHIC 65757
  Complete submission text file 0001447028-19-000071.txt   6511320

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT abus-20190930.xml EX-101.INS 736710
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20190930.xsd EX-101.SCH 44684
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20190930_cal.xml EX-101.CAL 78298
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20190930_def.xml EX-101.DEF 153658
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20190930_lab.xml EX-101.LAB 522780
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20190930_pre.xml EX-101.PRE 295206
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 191195651
SIC: 2834 Pharmaceutical Preparations